Inspira Technologies Expands HYLA Blood Sensor Tech
Ticker: IINNW · Form: 6-K · Filed: Dec 10, 2024 · CIK: 1837493
Sentiment: neutral
Topics: technology-expansion, medical-devices, diagnostics
TL;DR
Inspira's HYLA tech now targets personalized blood testing for faster disease detection.
AI Summary
On December 10, 2024, Inspira Technologies Oxy B.H.N. Ltd. announced the expansion of its HYLA Blood Sensor Technology into personalized blood lab testing. This move aims for the rapid detection of serious medical conditions.
Why It Matters
This expansion could lead to faster and more accessible diagnostics for critical health issues, potentially improving patient outcomes.
Risk Assessment
Risk Level: medium — The expansion into a new application area for their technology carries inherent market adoption and regulatory risks.
Key Players & Entities
- Inspira Technologies Oxy B.H.N. Ltd. (company) — Registrant
- HYLA Blood Sensor Technology (technology) — Product
- December 10, 2024 (date) — Announcement Date
FAQ
What is the primary purpose of expanding the HYLA Blood Sensor Technology?
The primary purpose is to enable personalized blood lab testing for the rapid detection of serious medical conditions.
When was this expansion announced?
The expansion was announced on December 10, 2024.
What is the name of the company making this announcement?
The company making the announcement is Inspira Technologies Oxy B.H.N. Ltd.
What specific technology is being expanded?
The HYLA Blood Sensor Technology is being expanded.
What type of report is this filing?
This filing is a Form 6-K, Report of Foreign Private Issuer.
Filing Stats: 316 words · 1 min read · ~1 pages · Grade level 9.1 · Accepted 2024-12-10 09:29:45
Filing Documents
- ea0224204-6k_inspira.htm (6-K) — 11KB
- ea022420401ex99-1_inspira.htm (EX-99.1) — 10KB
- 0001213900-24-107160.txt ( ) — 22KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. Inspira Technologies Oxy B.H.N. Ltd. Date: December 10, 2024 By: /s/ Dagi Ben-Noon Name: Dagi Ben-Noon Title: Chief Executive Officer 2